S
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Price:
30.14 CNY
7.84%
Market Closed
Updated:
Apr 30, 2024
Shanghai Junshi Biosciences Co Ltd
Net Income (Common)
|
Shanghai Junshi Biosciences Co Ltd
Net Income (Common) Peer Comparison
Comparables:
6160
1801
603392
S
002252
300122
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Shanghai Junshi Biosciences Co Ltd
SSE:688180
|
Net Income (Common)
-¥2.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Net Income (Common)
-¥13.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Income (Common)
-¥1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Income (Common)
¥1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Net Income (Common)
¥2.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Income (Common)
¥8.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
47%
|
CAGR 10-Years
45%
|
See Also
What is Shanghai Junshi Biosciences Co Ltd's Net Income (Common)?
Net Income (Common)
-2.3B
CNY
-2.3B
CNY
Based on the financial report for Dec 31, 2023, Shanghai Junshi Biosciences Co Ltd's Net Income (Common) amounts to -2.3B CNY.
What is Shanghai Junshi Biosciences Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-26%
-26%
Over the last year, the Net Income (Common) growth was 4%. The average annual Net Income (Common) growth rates for Shanghai Junshi Biosciences Co Ltd have been -11% over the past three years , -26% over the past five years .
You don't have any saved screeners yet
